1. A high cell density perfusion process for Modified Vaccinia virus Ankara production: Process integration with inline DNA digestion and cost analysis. Issue 12 (23rd September 2021) Authors: Gränicher, Gwendal; Babakhani, Masoud; Göbel, Sven; Jordan, Ingo; Marichal‐Gallardo, Pavel; Genzel, Yvonne; Reichl, Udo Journal: Biotechnology and bioengineering Issue: Volume 118:Issue 12(2021) Page Start: 4720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Continuous cell lines from the Muscovy duck as potential replacement for primary cells in the production of avian vaccines. Issue 2 (3rd March 2016) Authors: Jordan, Ingo; John, Katrin; Höwing, Kristin; Lohr, Verena; Penzes, Zoltán; Gubucz-Sombor, Erzsébet; Fu, Yan; Gao, Peng; Harder, Timm; Zádori, Zoltán; Sandig, Volker Journal: Avian pathology Issue: Volume 45:Issue 2(2016) Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Issue 1 (8th September 2020) Authors: Gränicher, Gwendal; Tapia, Felipe; Behrendt, Ilona; Jordan, Ingo; Genzel, Yvonne; Reichl, Udo Journal: Biotechnology journal Issue: Volume 16:Issue 1(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Purification of modified vaccinia virus Ankara from suspension cell culture. Issue 9 (December 2015) Authors: Jordan, Ingo; Weimer, Diana; Iarusso, Stefan; Bernhardt, Holger; Lohr, Verena; Sandig, Volker Journal: BMC proceedings Issue: Volume 9:Issue 9(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗